A MUTATION IN FBN1 DISRUPTS PROFIBRILLIN PROCESSING AND RESULTS IN ISOLATED SKELETAL FEATURES OF THE MARFAN-SYNDROME

被引:154
作者
MILEWICZ, DM
GROSSFIELD, J
CAO, SN
KIELTY, C
COVITZ, W
JEWETT, T
机构
[1] UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND
[2] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,WINSTON SALEM,NC 27157
关键词
FIBRILLIN EXTRACELLULAR MATRIX; ELASTIN-ASSOCIATED MICROFIBRILS; PROTEOLYTIC PROCESSING; NULL ALLELE;
D O I
10.1172/JCI117930
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dermal fibroblasts from a 13-yr-old boy with isolated skeletal features of the Marfan syndrome were used to study fibrillin synthesis and processing, Only one half of the secreted profibrillin was proteolytically processed to fibrillin outside the cell and deposited into the extracellular matrix, Electron microscopic examination of rotary shadowed microfibrils made by the proband's fibroblasts were indistinguishable from control cells, Sequencing of the FBN1 gene revealed a heterozygous C to T transition at nucleotide 8176 resulting in the substitution of a tryptophan for an arginine (R2726W), at a site immediately adjacent to a consensus sequence recognized by a cellular protease. Six other individuals in the proband's family had the FBN1 mutation that segregated with tall stature, None of the affected individuals have cardiac or ocular manifestations of the Marfan syndrome, This mutation identifies a putative site for profibrillin to fibrillin processing, and is associated with isolated skeletal features of the Marfan syndrome, indicating that the FBN1 gene is one of the genes that determines height in the general population, The cellular effect of the mutation may be equivalent to a ''null'' FBN1 allele and may define the phenotype associated with FBN1 ''null'' alleles.
引用
收藏
页码:2373 / 2378
页数:6
相关论文
共 35 条
  • [1] Pyeritz R.E., McKusick V.A., The Marfan syndrome: Diagnosis and management, N. Engl. J. Med., 300, pp. 772-777, (1979)
  • [2] Pyeritz R.E., The Marfan syndrome, Connective Tissue and Its Heritable Disorders, pp. 437-468, (1993)
  • [3] Murdoch J.L., Walker B.A., Halpera B.L., Kuzma J.W., McKusick V.A., Life expectancy and causes of death in the Marfan syndrome, N. Engl. J. Med., 286, pp. 804-808, (1972)
  • [4] Beighton P., DePaepe A., Danks D., Finidori G., Gedde-Dahl T., Goodman R., Hall J.G., Hollister D.W., Horton W., McKusick V.A., Et al., International nosology of heritable disorders of connective tissue, Berlin, Am. J. Med. Genet., 29, pp. 581-594, (1988)
  • [5] Dietz H.C., Cutting G.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson E.G., Puffenberger A., Hamosh A., Nanthakumar J., Curristin S.M., Et al., Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene, Nature (Lond.), 352, pp. 337-339, (1991)
  • [6] Lee B., Godfrey M., Vitale E., Hori H., Mattei M.G., Sarfarazi M., Tsipouras P., Ramirez F., Hollister D.W., Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes, Nature (Lond.), 352, pp. 330-334, (1991)
  • [7] Tsipouras P., DelMastro R., Sarfarazi M., Lee B., Child A.H., Godfrey M., Devereux R.B., Hewett D., Steinmann B., Vitale E., Et al., Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5, N. Engl. J. Med., 326, pp. 905-909, (1992)
  • [8] Dietz H.C., McIntosh I., Sakai L.Y., Corson G.M., Chalberg S.C., Pyeritz R.E., Francomano C.A., Four novel FBN1 mutations: Significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome, Genomics, 17, pp. 468-475, (1993)
  • [9] Sakai L.Y., Keene D.R., Engvall E., Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils, J. Cell Biol., 103, pp. 2499-2509, (1986)
  • [10] Dietz H.C., Saraiva J.M., Pyeritz R.E., Cutting G.R., Francomano C.A., Clustering of fibrillin missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains, Human Mutation, 1, pp. 366-374, (1992)